Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ritchie

Showing results (191-200 of 265) with videos related to

Pageof 27
Sort By:
Circulation. Heart Failure|March 5, 2015
Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivoNga Cao, Yung George Wong, Sarah Rosli, et al.
Frontiers in Pharmacology|March 15, 2021
Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid ArteriesJasmin Chendi Li, Anida Velagic, Cheng Xue Qin, et al.
Free Radical Biology & Medicine|March 5, 2013
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in miceKarina Huynh, Helen Kiriazis, Xiao-Jun Du, et al.
Diabetes|March 11, 2010
Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathyKarina Huynh, Julie R McMullen, Tracey L Julius, et al.
Plos One|November 13, 2012
The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophyJennifer C Irvine, Virat Ganthavee, Jane E Love, et al.
Pharmacological Research|December 19, 2016
Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complicationsCheng Xue Qin, Rochelle Sleaby, Amy J Davidoff, et al.
British Journal of Pharmacology|July 7, 2022
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35Cheng Xue Qin, Lucy V Norling, Elizabeth A Vecchio, et al.
Connective Tissue Research|December 23, 1998
Expression of dentin sialoprotein (DSP) and other molecular determinants by a new cell line from dental papillae, MDPC-23Z L Sun, D N Fang, X Y Wu, et al.
European Journal of Oral Sciences|December 12, 1997
Dentin sialoprotein (DSP) transcripts: developmentally-sustained expression in odontoblasts and transient expression in pre-ameloblastsH H Ritchie, J E Berry, M J Somerman, et al.
Journal of Molecular and Cellular Cardiology|May 11, 2007
The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivoR H Ritchie, J M Quinn, A H Cao, et al.
Pageof 27

Showing results (191-200 of 265) with videos related to

Sort By:
Pageof 27
Circulation. Heart Failure|March 5, 2015
Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivoNga Cao, Yung George Wong, Sarah Rosli, et al.
Frontiers in Pharmacology|March 15, 2021
Diabetes Attenuates the Contribution of Endogenous Nitric Oxide but Not Nitroxyl to Endothelium Dependent Relaxation of Rat Carotid ArteriesJasmin Chendi Li, Anida Velagic, Cheng Xue Qin, et al.
Free Radical Biology & Medicine|March 5, 2013
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in miceKarina Huynh, Helen Kiriazis, Xiao-Jun Du, et al.
Diabetes|March 11, 2010
Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathyKarina Huynh, Julie R McMullen, Tracey L Julius, et al.
Plos One|November 13, 2012
The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophyJennifer C Irvine, Virat Ganthavee, Jane E Love, et al.
Pharmacological Research|December 19, 2016
Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complicationsCheng Xue Qin, Rochelle Sleaby, Amy J Davidoff, et al.
British Journal of Pharmacology|July 7, 2022
Formylpeptide receptor 2: Nomenclature, structure, signalling and translational perspectives: IUPHAR review 35Cheng Xue Qin, Lucy V Norling, Elizabeth A Vecchio, et al.
Connective Tissue Research|December 23, 1998
Expression of dentin sialoprotein (DSP) and other molecular determinants by a new cell line from dental papillae, MDPC-23Z L Sun, D N Fang, X Y Wu, et al.
European Journal of Oral Sciences|December 12, 1997
Dentin sialoprotein (DSP) transcripts: developmentally-sustained expression in odontoblasts and transient expression in pre-ameloblastsH H Ritchie, J E Berry, M J Somerman, et al.
Journal of Molecular and Cellular Cardiology|May 11, 2007
The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivoR H Ritchie, J M Quinn, A H Cao, et al.
Pageof 27